Article info

PDF
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
  1. Correspondence to William G Dixon, Arthritis Research UK Epidemiology Unit, The University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; will.dixon{at}manchester.ac.uk
View Full Text

Citation

Dixon WG, Carmona L, Finckh A, et al
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

Publication history

  • Accepted 6 February 2010
  • Published in print 1 September 2010.
  • Published online 10 August 2010.
  • Published first 4 June 2010.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.